Intracranial Hemorrhage Devices Market Report 2025

This Intracranial Hemorrhage Devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The intracranial hemorrhage devices market size has grown strongly in recent years. It will grow from $1.71 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to factors such as the increasing incidence of hemorrhagic conditions, supportive government initiatives, favorable healthcare policies, a rise in lifestyle diseases, and the growing number of neurological specialty clinics.

The intracranial hemorrhage devices market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. For the forecast period, growth is expected due to factors such as the rising prevalence of traumatic injuries, efforts to reduce hospital stays, greater adoption of wearable monitoring devices, a higher demand for personalized medicine, and the increasing use of robotics. Key trends during this period include the development of portable devices, advancements in imaging and monitoring technologies, the rise of 3D printing, and the integration of machine learning in medical imaging.

The growing incidence of brain disorders is expected to drive the expansion of the intracranial hemorrhage devices market. Brain disorders encompass a variety of conditions that impact the structure, function, or chemistry of the brain, leading to disruptions in normal brain processes. The rising prevalence of these disorders is due to factors such as improved diagnostic methods, an aging population, lifestyle changes, increased awareness, and heightened stress levels. Intracranial hemorrhage devices are crucial for detecting, monitoring, and treating brain disorders related to bleeding. They help identify hemorrhages, manage pressure, and remove blood clots to prevent further damage to the brain. For example, in October 2022, the National Institutes of Health reported that in the United States, the number of new cases of primary brain and other central nervous system (CNS) tumors was estimated to be 93,470 in 2022, with an increase to 94,390 in 2023. Consequently, the rise in brain disorders is driving the demand for intracranial hemorrhage devices.

Leading companies in the intracranial hemorrhage devices market are focused on creating innovative products, such as advanced neuro access devices, to improve the precision and efficiency of diagnosing and treating brain injuries. These devices are specialized tools and technologies designed to provide accurate access to the brain or nervous system for diagnostic, surgical, or therapeutic purposes. For instance, in June 2024, Penumbra Inc., a medical device company based in the US, launched its advanced neuro access devices, BMX81 and BMX96, in Europe. These devices, designed for managing ischemic and hemorrhagic strokes, use advanced laser-cut stainless steel hypotube technology to enhance stability and trackability while allowing for larger inner diameters. This launch underscores Penumbra's dedication to improving stroke care in Europe.

In September 2024, Stryker Corporation, a US-based medical company, acquired NICO Corporation for an undisclosed amount. The acquisition aims to strengthen Stryker’s neurotechnology capabilities in tumor and stroke care, as well as expand its portfolio of solutions for tumor resection and the treatment of intracerebral hemorrhage. NICO Corporation, a US-based medical equipment manufacturer, specializes in devices for treating intracranial hemorrhage (ICH).

Major players in the intracranial hemorrhage devices market are Johnson & Johnson Services Inc., Medtronic Inc., Siemens Healthcare GmbH, Stryker Corporation, General Electric Company, Terumo Corporation, Canon Medical Systems Corporation, Penumbra Inc., MicroPort Scientific Corporation, Aidoc Medical Ltd., Viz.ai Inc., Phenox GmbH, RAPID AI Inc., Acandis GmbH, Kaneka Medix Corporation, Hyperfine Inc., ClearMind Biomedical Inc., InfraScan Inc., Schindler Endoskopie Technologie GmbH, Sense Neuro Diagnostics Inc., MaxQ AI Inc., and Invamed Inc.

North America was the largest region in the intracranial hemorrhage devices market in 2024. The regions covered in intracranial hemorrhage devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the intracranial hemorrhage devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Intracranial hemorrhage devices are medical tools designed for diagnosing, managing, and treating intracranial hemorrhages (ICH), which are bleeding events within the skull. These devices are essential for addressing conditions such as subdural hematoma, epidural hematoma, subarachnoid hemorrhage, and intracerebral hemorrhage.

The primary product categories for intracranial hemorrhage devices include diagnostic and treatment devices. Intracranial hemorrhage diagnosis refers to the process of detecting bleeding within the skull, utilizing both invasive and non-invasive devices. These devices serve various end users, such as hospitals, ambulatory surgical centers, and other healthcare facilities.

The intracranial hemorrhage devices market research report is one of a series of new reports that provides intracranial hemorrhage devices market statistics, including intracranial hemorrhage devices industry global market size, regional shares, competitors with an intracranial hemorrhage devices market share, detailed intracranial hemorrhage devices market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial hemorrhage devices industry. This intracranial hemorrhage devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intracranial hemorrhage devices market consists of sales of embolization devices, computed tomography scanners, balloon occlusion devices, and neuro-thrombectomy devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.